JAKAFI.COM: Keyword Density Checker

Total words: 3223 | 2-word phrases: 821 | 3-word phrases: 973 | 4-word phrases: 1042

PAGE INFO

Title	Try to keep the title under 60 characters (108 characters) Polycythemia Vera, Myelofibrosis, Acute & Chronic Graft-Versus-Host Disease & Jakafi® (ruxolitinib)
Description	Try to keep the meta description between 50 - 160 characters (574 characters) Learn about Jakafi® (ruxolitinib) – Used to treat adults with polycythemia vera who have taken hydroxyurea and it did not work well enough or they could not tolerate it, and adults with certain types of myelofibrosis. Jakafi is used to treat adults and children 12 years of age and older with acute graft-versus-host disease (GVHD) who have taken corticosteroids and they did not work well enough. Jakafi is also used to treat adults and children 12 years of age and older with chronic GVHD who have taken one or two types of treatments and they did not work well enough.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	treatment with jakafi	7	0.72%
2	during treatment with	6	0.62%
3	to treat adults	6	0.62%
4	work well enough	6	0.62%
5	jakafi is used	5	0.51%
6	is used to	5	0.51%
7	used to treat	5	0.51%
8	your healthcare provider	5	0.51%
9	and they did	4	0.41%
10	they did not	4	0.41%
11	blood cell counts	4	0.41%
12	certain types of	4	0.41%
13	increased risk of	4	0.41%
14	did not work	4	0.41%
15	treat adults with	4	0.41%
16	red blood cell	4	0.41%
17	gvhd who have	4	0.41%
18	have or had	4	0.41%
19	if you develop	4	0.41%
20	not work well	4	0.41%
21	risk of new	3	0.31%
22	well enough or	3	0.31%
23	healthcare provider will	3	0.31%
24	how jakafi is	3	0.31%
25	acute graftversushost disease	3	0.31%
26	jakafi tell your	3	0.31%
27	discover how jakafi	3	0.31%
28	tell your healthcare	3	0.31%
29	us residents only	3	0.31%
30	children 12 years	3	0.31%

#	Keyword	Frequency	Density
1	during treatment with jakafi	6	0.58%
2	jakafi is used to	5	0.48%
3	used to treat adults	5	0.48%
4	is used to treat	5	0.48%
5	not work well enough	4	0.38%
6	did not work well	4	0.38%
7	and they did not	4	0.38%
8	to treat adults and	3	0.29%
9	treat adults and children	3	0.29%
10	work well enough or	3	0.29%
11	and children 12 years	3	0.29%
12	age and older with	3	0.29%
13	to treat adults with	3	0.29%
14	right away if you	3	0.29%
15	gvhd who have taken	3	0.29%
16	discover how jakafi is	3	0.29%
17	how jakafi is used	3	0.29%
18	adults and children 12	3	0.29%
19	children 12 years of	3	0.29%
20	for us residents only	3	0.29%
21	intended for us residents	3	0.29%
22	well enough or they	2	0.19%
23	with jakafi tell your	2	0.19%
24	insurance coverage explore financial	2	0.19%
25	already taken a medicine	2	0.19%
26	have already taken a	2	0.19%
27	or two types of	2	0.19%
28	assistance options and offer	2	0.19%
29	two types of treatments	2	0.19%
30	ongoing support learn more	2	0.19%
31	registered trademarks of incyte	2	0.19%
32	who have already taken	2	0.19%
33	treatment with jakafi tell	2	0.19%
34	increased risk of new	2	0.19%
35	red blood cell counts	2	0.19%
36	or red blood cell	2	0.19%
37	types of treatments and	2	0.19%
38	certain types of myelofibrosis	2	0.19%
39	treat adults with polycythemia	2	0.19%
40	of treatments and they	2	0.19%

#	URL	Whois	Check
1	https://www.incytecares.com/	Whois	incytecares.com
2	https://www.incytecares.com	Whois	incytecares.com
3	https://www.incytecares.com	Whois	incytecares.com
4	https://www.fda.gov/Safety/MedWatch/default.htm	Whois	fda.gov
5	https://incyte.com/privacy-policy	Whois	incyte.com
6	https://incyte.com/legal-notice	Whois	incyte.com
7	https://incyte.com/consumer-health-data-privacy-policy	Whois	incyte.com
8	https://incyte.com/cookies	Whois	incyte.com
9	https://incyte.com/	Whois	incyte.com
10	https://incyte.com/	Whois	incyte.com